大补身汤通过靶向DNMT1保护PPARγ改善骨关节炎的活性成分解析
本研究探讨敦煌古方大补身汤(DD)治疗骨关节炎(OA)的疗效与物质基础。在OA大鼠模型中,DD可上调PPARγ表达并促进胶原合成;通过分子对接筛选出7种潜在活性成分,其中5种(泽泻醇A、大黄素、花旗松素、异甘草素、五味子丙素)可促进PPARγ表达并改善IL-1β诱导的胶原II下调和MMP-13生成,泽泻醇A和大黄素能有效减轻软骨损伤;分子动力学模拟显示这5种成分与DNMT1稳定结合。结论提示DD活性成分通过靶向DNMT1保护PPARγ改善OA。
要点
- 大补身汤在OA大鼠模型中上调PPARγ并促进胶原合成。
- 泽泻醇A、大黄素、花旗松素、异甘草素、五味子丙素可促进PPARγ表达。
- 泽泻醇A和大黄素能有效减轻软骨损伤。
核心结论
- 大补身汤的活性成分(泽泻醇A、大黄素、花旗松素、异甘草素、五味子丙素)通过靶向DNMT1保护PPARγ改善骨关节炎。
研究设计与样本
- 研究采用OA大鼠模型,运用Micro-CT、HE染色、S-O染色和免疫组化分析。
- 通过分子对接筛选大补身汤活性成分,并用蛋白毛细管电泳、免疫荧光和大鼠膝关节软骨离体培养评估软骨细胞保护作用。
- 最后采用分子动力学模拟与MM-GBSA方法研究活性成分与DNMT1复合物的相互作用模式。
主要发现
- 大补身汤在OA大鼠模型中增加PPARγ表达和胶原合成。
- 分子对接筛选出7种潜在活性成分:异甘草素、大黄素、花旗松素、梓醇、泽泻醇A、姜酮和五味子丙素。
- 泽泻醇A、大黄素、花旗松素、异甘草素和五味子丙素可促进PPARγ表达,并改善IL-1β诱导的胶原II下调和MMP-13生成。
- 泽泻醇A和大黄素能有效减轻软骨损伤。
- 5种成分与DNMT1形成稳定结合模式,其中泽泻醇A具有相对较高的结合自由能。
临床怎么用
- 大补身汤可作为OA治疗的潜在方剂,其活性成分泽泻醇A和大黄素可能具有软骨保护作用。
- 该研究为从中药复方中开发天然表观遗传调节剂提供了策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Osteoarthritis (OA) is a multifactorial and chronic degenerative joint disease. Due to the adverse effects of currently used drugs, a safer and more effective therapy for treating OA is needed. Peroxisome proliferator-activated receptor-γ (PPARγ) is a key protein protecting cartilage. DNMT1-mediated hypermethylation of PPARγ promoter leads to its suppression. Therefore, DNMT1 might be an effective target for exerting cartilage protective effects by regulating the epigenetic expression of PPARγ. Dabushen decoction (DD) is a representative prescription of Dunhuang ancient medical prescription, which has a potential therapeutic effect on OA. So far, the research of the efficacy and material basis of DD in the treatment of OA remains unclear. In this study, Micro-CT, HE staining, S-O staining, and immunohistochemistry analysis were used to demonstrate that DD increased the expression of PPARγ and collagen synthesis in an OA rat model. Next, the structure of DNMT1 was used to screen the active constituents of DD by molecular docking method for treatment OA. Seven potential active constituents, including isoliquiritigenin, emodin, taxifolin, catalpol, alisol A, zingerone, and schisandrin C were hited. The protective effect of the potential active constituents to chondrocytes were evaluated by protein capillary electrophoresis, immunofluorescence assays, and ex vivo culture of rat knee cartilage. The five constituents, such as alisol A, emodin, taxifolin, isoliquiritigenin, and schisandrin C could promote the expression of PPARγ and ameliorate IL-1β-induced downregulation of collagen II and the production of MMP-13. Alisol A and Emodin could effectively mitigate cartilage damage. At last, molecular dynamics simulations with MM-GBSA method was applied to investigate the interaction pattern of the active constituents and DNMT1 complexes. The five constituents, such as alisol A, emodin, taxifolin, isoliquiritigenin, and schisandrin C achieved a stable binding pattern with DNMT1, in which alisol A has a relatively high binding free energy. In conclusion, this study elucidates that the active constituents of DD (alisol A, emodin, taxifolin, isoliquiritigenin, and schisandrin C) could ameliorate osteoarthritis via PPARγ preservation by targeting DNMT1.These findings facilitated clinical use of DD and provided a valuable strategy for developing natural epigenetic modulators from Chinese herbal formula.
引用
- Qiu L, Zhang M, Li C, et al. Deciphering the active constituents of Dabushen decoction of ameliorating osteoarthritis via PPARγ preservation by targeting DNMT1. Front Pharmacol. 2022. PMID: 36506533. doi:10.3389/fphar.2022.993498
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。